These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30721964)

  • 1. A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials.
    Li K; Strauss R; Marano C; Greenbaum LE; Friedman JR; Peyrin-Biroulet L; Brodmerkel C; De Hertogh G
    J Crohns Colitis; 2019 Aug; 13(8):1025-1035. PubMed ID: 30721964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
    Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY).
    Peyrin-Biroulet L; Loftus EV; Colombel JF; Danese S; Rogers R; Bornstein JD; Chen J; Schreiber S; Sands BE; Lirio RA
    Gastroenterology; 2021 Oct; 161(4):1156-1167.e3. PubMed ID: 34144047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
    Yarur AJ; Chiorean MV; Panés J; Jairath V; Zhang J; Rabbat CJ; Sandborn WJ; Vermeire S; Peyrin-Biroulet L
    J Crohns Colitis; 2024 Jun; 18(6):885-894. PubMed ID: 38245818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
    Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
    Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
    Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis.
    Narula N; Wong ECL; Colombel JF; Riddell R; Marshall JK; Reinisch W; Dulai PS
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1095-1104.e9. PubMed ID: 34229037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.
    Lazzerini M; Villanacci V; Pellegrin MC; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Fontana M; Zuin G; Maggiore G; Bramuzzo M; Maschio M; Salemme M; Manenti S; Lorenzi L; Decorti G; Montico M; Ventura A
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1382-1389.e1. PubMed ID: 28286192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy.
    Magro F; Alves C; Lopes J; Lopes S; Tavares de Sousa H; Cotter J; Macedo da Silva V; Lago P; Vieira A; Brito M; Duarte MAM; Portela F; Silva JP; Ministro P; Arroja B; Carvalho L; Torres J; Santiago M; Estevinho MM; Danese S; Peyrin-Biroulet L; Dias CC; Borralho P; Feakins RM; Carneiro F
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2567-2576.e9. PubMed ID: 32920215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients With Ulcerative Colitis.
    Takenaka K; Ohtsuka K; Fujii T; Negi M; Suzuki K; Shimizu H; Oshima S; Akiyama S; Motobayashi M; Nagahori M; Saito E; Matsuoka K; Watanabe M
    Gastroenterology; 2020 Jun; 158(8):2150-2157. PubMed ID: 32060000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Nanda KS; Zenlea T; Gifford A; Lawlor GO; Falchuk KR; Wolf JL; Cheifetz AS; Goldsmith JD; Moss AC
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):991-6. PubMed ID: 23591275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.